Moderna Initiates Rolling Submission to Health Canada for mRNA-1273 Against COVID-19

 Moderna Initiates Rolling Submission to Health Canada for mRNA-1273 Against COVID-19

Moderna Initiates Rolling Submission to Health Canada for mRNA-1273 Against COVID-19 (mRNA-1273)

Shots:

  • The initiation of a rolling submission follows positive results from a preclinical viral challenge study of mRNA-1273 and the +ve interim analysis of the P-l study of mRNA-1273 in healthy adults (aged 18-55 yrs.) and older adults (aged 56-70 and 71+), published in the NEJM
  • Moderna has become the third maker that initiates the rolling submission to Health Canada for speeding up the approval. Health Canada is already conducting real-time reviews of BioNTech & Pfizer’s COVID-19 vaccine candidates along with AstraZeneca’s candidate
  • The rolling reviews speed up the process of approving a vaccine, allowing researchers to submit findings in real-time, without having to wait for studies to conclude

    Click here to­ read the full press release/ article | Ref: Moderna | Image: Sky News

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post